Privia Health Group (NASDAQ:PRVA) Now Covered by Analysts at Needham & Company LLC

Needham & Company LLC began coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research report sent to investors on Friday, MarketBeat.com reports. The brokerage issued a buy rating and a $25.00 price target on the stock.

Several other analysts have also recently commented on the stock. Macquarie initiated coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. JPMorgan Chase & Co. increased their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Truist Financial lifted their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. KeyCorp assumed coverage on Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 target price for the company. Finally, Barclays boosted their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $24.88.

Privia Health Group Price Performance

Shares of PRVA opened at $20.51 on Friday. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $23.24. The company has a 50 day simple moving average of $20.93 and a two-hundred day simple moving average of $19.43. The firm has a market cap of $2.46 billion, a P/E ratio of 205.12, a price-to-earnings-growth ratio of 5.45 and a beta of 0.85.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Canada Pension Plan Investment Board purchased a new position in Privia Health Group during the 2nd quarter valued at $26,000. GAMMA Investing LLC boosted its stake in shares of Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares during the period. Quarry LP boosted its stake in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares during the period. KBC Group NV grew its holdings in shares of Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after purchasing an additional 871 shares during the last quarter. Finally, Neo Ivy Capital Management purchased a new position in Privia Health Group in the 3rd quarter worth about $66,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.